The role of PARP1 in breast cancer is preeminent in BRCA1/2 mutations that impair homologous recombination repair (HRR) and make cells reliant on PARP1-catalyzed base excision repair (BER) for existence. This evidence concerns the gene PARP1 and breast carcinoma.